A series of new unsymmetrical (XYC–1 type) palladacycles (C1–C4) were designed and synthesized with simple anchoring ligands L1–4H (L1H = 2‐((2‐(4‐methoxybenzylidene)‐1‐phenylhydrazinyl)methyl)pyridine, L2H = N,N‐dimethyl‐4‐((2‐phenyl‐2‐(pyridin‐2‐ylmethyl)hydrazono)methyl)aniline, L3H = N,N‐diethyl‐4‐((2‐phenyl‐2‐(pyridin‐2‐ylmethyl)hydrazono)methyl) aniline and L4H = 4‐(4‐((2‐phenyl‐2‐(pyridin‐2‐ylmethyl)hydrazono) methyl)phenyl)morpholine H = dissociable proton). Molecular structure of catalysts (C1–C4) were further established by single X‐ray crystallographic studies. The catalytic performance of palladacycles (C1–C4) was explored with the direct Csp2–H arylation of imidazoles with aryl halide derivatives. These palladacycles were also applied for investigating of Mizoroki–Heck reactions with aryl halides and acrylate derivatives. During catalytic cycle in situ generated Pd(0) nanoparticles were characterized by XPS, SEM and TEM analysis and possible reaction pathways were proposed. The catalyst was employed as a pre‐catalyst for the gram‐scale synthesis of octinoxate, which is utilized as a UV‐B sunscreen agent.

The chemotherapeutic potential of ruthenium(II) complexes has recently attracted researchers' interest as antibacterial and anticancer agents. In this study, two novel half-sandwich imine-based Ru-complexes ([Ru(p-cymene)Cl(L-1)][PF6] (Ru-1), and [Ru(p-cymene)Cl(L-2)][PF6] (Ru-2)) were...

No abstract

No abstract

No abstract